Recall of Device Recall Nova StatStrip Glucose Test Strips

According to U.S. Food and Drug Administration, this recall involved a device in United States that was produced by Nova Biomedical Corporation.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    54630
  • Event Risk Class
    Class 2
  • Event Number
    Z-1783-2010
  • Event Initiated Date
    2010-02-12
  • Event Date Posted
    2010-06-10
  • Event Status
    Terminated
  • Event Country
  • Event Terminated Date
    2011-07-22
  • Event Source
    USFDA
  • Event Source URL
  • Notes / Alerts
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Extra notes in the data
    Glucose oxidase, glucose - Product Code CGA
  • Reason
    Glucose strips report low glucose results.
  • Action
    Nova Biomedical notified it's domestic Consignees by a Customer Advisory Notice by phone and follow up by email and/or fax dated February 12, 2010. The firm will replace all affected inventory at customer sites via overnight shipment of replacement Test Strips to customer site. For further information, contact your local Nova Support Department or call 1-800-545-6682.

Device

  • Model / Serial
    Lot Number: 0309019249, Expiration Date: 1/31/2011.
  • Product Classification
  • Device Class
    2
  • Implanted device?
    No
  • Distribution
    Worldwide Distribution -- United States (CO, MA, MN and RI), United Kingdom, Germany, France and Italy.
  • Product Description
    Nova StatStrip Glucose Test Strips, Catalog Number: 42214. Nova Biomedical Corporation. Waltham, MA 02454. || Intended for in vitro diagnostic use by health care professionals and for Point-Of-Care usage for the quantitative measurement of glucose in capillary, venous, arterial and neonate whole blood.
  • Manufacturer

Manufacturer

  • Manufacturer Address
    Nova Biomedical Corporation, 200 Prospect St, Waltham MA 02453
  • Manufacturer Parent Company (2017)
  • Source
    USFDA